In colorectal cancer (CRC), higher levels of CDH17 correlate with higher tumour grades and lymphatic invasion [13,14,15], and, in pancreatic tumours (PC), it is linked to dedifferentiation and poor survival [16,17]. Here, CDH17 is linked to colorectal carcinoma.